Savara (SVRA) Assets Average (2011 - 2026)
Savara's (SVRA) quarterly Assets Average came in at $237.5 million in Q1 2026, up 18.12% year-on-year from $201.1 million in Q1 2025, and up 20.47% on a QoQ basis from $197.2 million in Q4 2025.
Savara (SVRA) Assets Average (2011 - 2026) Analysis & Trends
Savara (SVRA) has 16 years of Assets Average data on file, last reported at $237.5 million in Q1 2026.
- On a quarterly basis, Assets Average rose 18.12% year-over-year to $237.5 million in Q1 2026; TTM through Mar 2026 was $237.5 million, a 18.12% increase from a year earlier, with the FY2025 full-year figure at $233.2 million, up 19.43% from the prior year.
- Assets Average for Q1 2026 stood at $237.5 million, up from $197.2 million in the prior quarter.
- Over the last five years, Assets Average for SVRA reached as high as $237.5 million in Q1 2026 and fell as low as $124.6 million in Q2 2023.
- Historically, Assets Average has averaged $171.5 million across 5 years, with a median of $167.9 million in 2024.
- Across the five-year window, Assets Average decreased 22.85% in 2023 and gained 25.6% in 2024, its largest moves.
- Year by year, Assets Average stood at $143.8 million in 2022, then grew by 25.08% to $179.8 million in 2023, then rose by 25.6% to $225.8 million in 2024, then decreased by 12.69% to $197.2 million in 2025, then grew by 20.47% to $237.5 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $237.5 million in Q1 2026, $197.2 million in Q4 2025, and $152.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 237.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 237.54 Mn |
| Dec 31, 2025 | 197.18 Mn |
| Sep 30, 2025 | 152.34 Mn |
| Jun 30, 2025 | 176.54 Mn |
| Mar 31, 2025 | 201.10 Mn |
| Dec 31, 2024 | 225.85 Mn |
| Sep 30, 2024 | 189.24 Mn |
| Jun 30, 2024 | 148.98 Mn |
| Mar 31, 2024 | 167.93 Mn |
| Dec 31, 2023 | 179.82 Mn |
| Sep 30, 2023 | 150.95 Mn |
| Jun 30, 2023 | 124.60 Mn |
| Mar 31, 2023 | 134.57 Mn |
| Dec 31, 2022 | 143.77 Mn |
| Sep 30, 2022 | 152.27 Mn |
| Jun 30, 2022 | 161.49 Mn |
| Mar 31, 2022 | 171.40 Mn |
| Dec 31, 2021 | 181.94 Mn |
| Sep 30, 2021 | 191.85 Mn |
| Jun 30, 2021 | 202.03 Mn |